Latest evidence on unique self-expanding technology: long-term results with CoreValve and initial results with CoreValve Evolut R

With an educational grant from MEDTRONIC

Chairperson: A. Vahanian
Co-chairperson: R. Kornowski

Learning Objectives

  • To assess the long-term performance of self-expanding CoreValve platform with the CoreValve ADVANCE study 3-year outcomes
  • To gain insights into the latest long-term outcomes from world's largest TAVI prospective randomised clinical trial: the CoreValve US pivotal study
  • To attend the first presentation worldwide of the 6-month outcomes of Evolut R CE-marked study

Presentations available when logged in:

  • The CoreValve ADVANCE study - 3-year results
  • Latest insights on the CoreValve US pivotal high-risk 2-year data
  • How technology translates into clinical advancement: the Evolut R platform
  • Evolut R 26 and 29 CE study: 6-month results
  • Session evaluation and key learnings